This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

. 2008 Feb;49(2):479-89.

doi: 10.1167/iovs.07-1132.

Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium

Karl G Csaky¹, Elaine A Richman, Frederick L Ferris 3rd

Affiliations

PMID: 18234989
DOI: 10.1167/iovs.07-1132

Report from the NEI/FDA Ophthalmic Clinical Trial Design and Endpoints Symposium

Karl G Csaky et al. Invest Ophthalmol Vis Sci. 2008 Feb.

. 2008 Feb;49(2):479-89.

doi: 10.1167/iovs.07-1132.

Authors

Karl G Csaky¹, Elaine A Richman, Frederick L Ferris 3rd

Affiliation

¹ Ophthalmic Unit, DCRI, Duke University Medical Center, Durham, NC 27710, USA. karl.csaky@duke.edu

PMID: 18234989
DOI: 10.1167/iovs.07-1132

No abstract available

PubMed Disclaimer

Similar articles

The glaucoma research community and FDA look to the future: a report from the NEI/FDA CDER Glaucoma Clinical Trial Design and Endpoints Symposium.
Weinreb RN, Kaufman PL. Weinreb RN, et al. Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1497-505. doi: 10.1167/iovs.08-2843. Invest Ophthalmol Vis Sci. 2009. PMID: 19321793 No abstract available.
Glaucoma research community and FDA look to the future, II: NEI/FDA Glaucoma Clinical Trial Design and Endpoints Symposium: measures of structural change and visual function.
Weinreb RN, Kaufman PL. Weinreb RN, et al. Invest Ophthalmol Vis Sci. 2011 Oct 4;52(11):7842-51. doi: 10.1167/iovs.11-7895. Invest Ophthalmol Vis Sci. 2011. PMID: 21972262 Free PMC article. No abstract available.
Responsiveness of the National Eye Institute Visual Function Questionnaire to changes in visual acuity: findings in patients with subfoveal choroidal neovascularization--SST Report No. 1.
Miskala PH, Hawkins BS, Mangione CM, Bass EB, Bressler NM, Dong LM, Marsh MJ, McCaffrey LD; Submacular Surgery Trials Research Group. Miskala PH, et al. Arch Ophthalmol. 2003 Apr;121(4):531-9. doi: 10.1001/archopht.121.4.531. Arch Ophthalmol. 2003. PMID: 12695250 Free PMC article. Clinical Trial.
[New drug VEGF Trap-Eye--Eylea--and its use in the treatment of age-related macular degeneration, central retinal vein occlusion, diabetic macular edema, and choroidal neovascularization secondary to pathologic myopia].
Rejdak R, Szkaradek M, Taslaq W, Kałuzny JJ, Grieb P, Jünemann AG. Rejdak R, et al. Klin Oczna. 2012;114(4):308-10. Klin Oczna. 2012. PMID: 23461161 Review. Polish.
Report From the NEI/FDA Diabetic Retinopathy Clinical Trial Design and Endpoints Workshop.
Nair P, Aiello LP, Gardner TW, Jampol LM, Ferris FL III. Nair P, et al. Invest Ophthalmol Vis Sci. 2016 Oct 1;57(13):5127-5142. doi: 10.1167/iovs.16-20356. Invest Ophthalmol Vis Sci. 2016. PMID: 27699406 Free PMC article. Review. No abstract available.

See all similar articles

Cited by

Long-Term Investigation of Retinal Function in Patients with Achromatopsia.
Georgiou M, Singh N, Kane T, Zaman S, Hirji N, Aboshiha J, Kumaran N, Kalitzeos A, Carroll J, Weleber RG, Michaelides M. Georgiou M, et al. Invest Ophthalmol Vis Sci. 2020 Sep 1;61(11):38. doi: 10.1167/iovs.61.11.38. Invest Ophthalmol Vis Sci. 2020. PMID: 32960951 Free PMC article.
Determinants of Quality of Life in Geographic Atrophy Secondary to Age-Related Macular Degeneration.
Künzel SH, Möller PT, Lindner M, Goerdt L, Nadal J, Schmid M, Schmitz-Valckenberg S, Holz FG, Fleckenstein M, Pfau M. Künzel SH, et al. Invest Ophthalmol Vis Sci. 2020 May 11;61(5):63. doi: 10.1167/iovs.61.5.63. Invest Ophthalmol Vis Sci. 2020. PMID: 32462198 Free PMC article.
Geographic atrophy in patients with advanced dry age-related macular degeneration: current challenges and future prospects.
Danis RP, Lavine JA, Domalpally A. Danis RP, et al. Clin Ophthalmol. 2015 Nov 20;9:2159-74. doi: 10.2147/OPTH.S92359. eCollection 2015. Clin Ophthalmol. 2015. PMID: 26640366 Free PMC article. Review.
Assessment of CRB1-Associated Retinopathies Using the S-MAIA Fast Protocol and Spectral-Domain Optical Coherence Tomography.
Higgins BE, Rodriguez-Martinez AC, Montesano G, Tailor-Hamblin VK, Malka S, Henderson RH, Moosajee M. Higgins BE, et al. Biomedicines. 2025 Feb 21;13(3):555. doi: 10.3390/biomedicines13030555. Biomedicines. 2025. PMID: 40149532 Free PMC article.
Visual Acuity Outcomes after Anti-Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: Age-Related Eye Disease Study 2 Report Number 19.
Keenan TD, Vitale S, Agrón E, Domalpally A, Antoszyk AN, Elman MJ, Clemons TE, Chew EY; Age-Related Eye Disease Study 2 Research Group. Keenan TD, et al. Ophthalmol Retina. 2020 Jan;4(1):3-12. doi: 10.1016/j.oret.2019.06.001. Epub 2019 Jun 11. Ophthalmol Retina. 2020. PMID: 31395505 Free PMC article. Clinical Trial.

See all "Cited by" articles

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Silverchair Information Systems
Other Literature Sources
- The Lens - Patent Citations Database
Medical
- MedlinePlus Health Information